Crescent Grove Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $2.25M | Sell |
|
|||||
|
2023
Q4 | $1.75M | Sell |
|
|||||
|
2023
Q3 | $1.62M | Buy |
|
|||||
|
2023
Q2 | $1.38M | Sell |
|
|||||
|
2023
Q1 | $1.02M | Buy |
|
|||||
|
2022
Q4 | $1.05M | Buy |
|
|||||
|
2022
Q3 | $922K | Sell |
|
|||||
|
2022
Q2 | $942K | Hold |
|
|||||
|
2022
Q1 | $832K | Buy |
|
|||||
|
2021
Q4 | $783K | Buy |
|
|||||
|
2021
Q3 | $597K | Hold |
|
|||||
|
2021
Q2 | $593K | Sell |
|
|||||
|
2021
Q1 | $540K | Buy |
|
|||||
|
2020
Q4 | $454K | Hold |
|
|||||
|
2020
Q3 | $398K | Hold |
|
|||||
|
2020
Q2 | $442K | Buy |
|
|||||
|
2020
Q1 | $366K | Sell |
|
|||||
|
2019
Q4 | $372K | Buy |
|
|||||
|
2019
Q3 | $260K | Hold |
|
|||||
|
2019
Q2 | $258K | Sell |
|
|||||
|
2019
Q1 | $310K | Sell |
|
|||||
|
2018
Q4 | $296K | Buy |
|
|||||
|
2018
Q3 | $229K | Buy |
|